CELEX: 22019D2053
Language: en
Date: 2018-02-09 00:00:00
Title: Decision of the EEA Joint Committee No 17/2018 of 9 February 2018 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2019/2053]

12.12.2019   
               
               
                  EN
               
               
                  Official Journal of the European Union
               
               
                  L 323/33
               
            
         DECISION OF THE EEA JOINT COMMITTEE
         No 17/2018
         of 9 February 2018
         amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2019/2053]
         THE EEA JOINT COMMITTEE,
         Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,
         Whereas:
         
                     (1)
                  
                  
                     Commission Implementing Regulation (EU) 2017/2001 of 8 November 2017 approving propan-1-ol as an existing active substance for use in biocidal products of product-type 1, 2 and 4 (1) is to be incorporated into the EEA Agreement.
                  
               
                     (2)
                  
                  
                     Commission Implementing Regulation (EU) 2017/2002 of 8 November 2017 approving L(+) lactic acid as an existing active substance for use in biocidal products of product-types 2, 3 and 4 (2) is to be incorporated into the EEA Agreement.
                  
               
                     (3)
                  
                  
                     Commission Implementing Regulation (EU) 2017/2003 of 8 November 2017 approving fludioxonil as an active substance for use in biocidal products of product-types 7, 9 and 10 (3) is to be incorporated into the EEA Agreement.
                  
               
                     (4)
                  
                  
                     Commission Implementing Regulation (EU) 2017/2004 of 8 November 2017 approving 2-methylisothiazol-3(2H)-one as an existing active substance for use in biocidal products of product-type 12 (4) is to be incorporated into the EEA Agreement.
                  
               
                     (5)
                  
                  
                     Commission Implementing Regulation (EU) 2017/2005 of 8 November 2017 approving margosa extract, cold-pressed oil of Azadirachta indica seeds without shells extracted with super-critical carbon dioxide as an existing active substance for use in biocidal products of product-type 19 (5) is to be incorporated into the EEA Agreement.
                  
               
                     (6)
                  
                  
                     Annex II to the EEA Agreement should therefore be amended accordingly,
                  
               HAS ADOPTED THIS DECISION:
         
            Article 1
            The following points are inserted after point 20 (Commission Implementing Decision (EU) 2017/1532) of Chapter XV of Annex II to the EEA Agreement:
            
                        ‘21.
                     
                     
                        
                           32017 R 2001: Commission Implementing Regulation (EU) 2017/2001 of 8 November 2017 approving propan-1-ol as an existing active substance for use in biocidal products of product-type 1, 2 and 4 (OJ L 290, 9.11.2017, p. 1).
                     
                  
                        22.
                     
                     
                        
                           32017 R 2002: Commission Implementing Regulation (EU) 2017/2002 of 8 November 2017 approving L(+) lactic acid as an existing active substance for use in biocidal products of product-types 2, 3 and 4 (OJ L 290, 9.11.2017, p. 4).
                     
                  
                        23.
                     
                     
                        
                           32017 R 2003: Commission Implementing Regulation (EU) 2017/2003 of 8 November 2017 approving fludioxonil as an active substance for use in biocidal products of product-types 7, 9 and 10 (OJ L 290, 9.11.2017, p. 7).
                     
                  
                        24.
                     
                     
                        
                           32017 R 2004: Commission Implementing Regulation (EU) 2017/2004 of 8 November 2017 approving 2-methylisothiazol-3(2H)-one as an existing active substance for use in biocidal products of product-type 12 (OJ L 290, 9.11.2017, p. 11).
                     
                  
                        25.
                     
                     
                        
                           32017 R 2005: Commission Implementing Regulation (EU) 2017/2005 of 8 November 2017 approving margosa extract, cold-pressed oil of Azadirachta indica seeds without shells extracted with super-critical carbon dioxide as an existing active substance for use in biocidal products of product-type 19 (OJ L 290, 9.11.2017, p. 14).’
                     
                  
         
            Article 2
            The texts of Implementing Regulations (EU) 2017/2001, (EU) 2017/2002, (EU) 2017/2003, (EU) 2017/2004 and (EU) 2017/2005 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
         
         
            Article 3
            This Decision shall enter into force on 10 February 2018, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
         
         
            Article 4
            This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
         
         
            Done at Brussels, 9 February 2018.
            
               
                  For the EEA Joint Committee
               
               
                  The President
               
               Claude MAERTEN
            
         
         
            (1)  OJ L 290, 9.11.2017, p. 1.
         
            (2)  OJ L 290, 9.11.2017, p. 4.
         
            (3)  OJ L 290, 9.11.2017, p. 7.
         
            (4)  OJ L 290, 9.11.2017, p. 11.
         
            (5)  OJ L 290, 9.11.2017, p. 14.
         
            (*1)  No constitutional requirements indicated.